ArticleCureus2025
Estimating Survival Functions in Children With Malaria in South Sudan: A Comparative Analysis of Associated Factors.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMalaria remains one of the major health problems worldwide. It is a leading cause of morbidity and mortality in South Sudan, especially in children. The aim of this study was to estimate the survival functions of children with malaria and to compare these functions with respect to the associated factors.
methodsThis was a retrospective cohort study that utilized data extracted from records of children aged 1 month to 15 years who were diagnosed with malaria and admitted to Al Sabah Children's Hospital, Juba, South Sudan from 1 January to 31 December 2021. Kaplan-Meier was employed to estimate the survival functions, and the log-rank test statistic was used to compare survival curves with respect to categories of specific covariates.
resultsOut of 6,410 children diagnosed with malaria who were included in this study, 3,595 (56.08%) were males and 2815 (43.92%) were females. A total of 303 (4.73%) died and 6,107 (95.27%) were censored. The median survival time was three days (IQR 2-4), and the mean age of the study cohort was 23.66 months (95% CI: 23.01 to 24.32). Comorbidity status among children indicated that 1,552 (24.01%) had comorbidities during admission. With respect to the treatment covariate, 3,920 (61.15%) were treated with artesunate. Kaplan-Meier survival curves showed increased survival for children treated with quinine and those without comorbidity. The log-rank test revealed that the covariates treatment and comorbidity were significant (p < 0.05), both having an impact on survival among children.
conclusionThis study found that the median survival time for children with malaria was three days. Additionally, comorbidity decreased survival among children. Treatment with quinine showed better survival rates compared to artesunate, despite studies suggesting artesunate as a replacement for quinine. Strengthening the healthcare system, provision of good-quality drugs, and implementing control intervention measures to reduce the transmission of malaria are essential for improving child survival in the country. Furthermore, it is essential to carry out a comparative study of quinine and artesunate for the treatment of malaria. Future studies on malaria in South Sudan have to be conducted by using a prospective study design to address the challenges of incomplete data and potential biases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.